scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1020426374 |
P356 | DOI | 10.1007/S10354-013-0179-3 |
P698 | PubMed publication ID | 23392810 |
P50 | author | Werner Jaschke | Q64535794 |
P2093 | author name string | Johannes Petersen | |
Benjamin Henninger | |||
P2860 | cites work | Management of hepatocellular carcinoma: An update | Q27860530 |
Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT. | Q33183669 | ||
Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review | Q33236732 | ||
Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation | Q33589095 | ||
Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings | Q33967898 | ||
Hepatocellular carcinoma: global epidemiology | Q34247384 | ||
CT evaluation of the liver: principles and techniques | Q34298603 | ||
Magnetic resonance imaging of the liver: New imaging strategies for evaluating focal liver lesions | Q34391672 | ||
Hepatic imaging with multidetector CT. | Q34399669 | ||
MR imaging of the liver using gadolinium chelates | Q34428460 | ||
Hepatocellular carcinoma: detection with triple-phase multi-detector row helical CT in patients with chronic hepatitis | Q34531011 | ||
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. | Q34585928 | ||
Multidetector helical CT of the liver for tumor detection and characterization | Q34605118 | ||
Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: frequency and causes of false-positive interpretation | Q35088765 | ||
Ultrasonographic detection of focal liver lesions: increased sensitivity and specificity with microbubble contrast agents | Q35114542 | ||
Contrast optimization and scan timing for single and multidetector-row computed tomography | Q35196069 | ||
Liver imaging with multidetector helical computed tomography | Q35196073 | ||
Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians | Q35207733 | ||
Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. | Q35852165 | ||
Multidetector CT: contributions in liver imaging | Q35893916 | ||
Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT. | Q36350027 | ||
An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography | Q36457263 | ||
Detection and characterization of benign focal liver lesions with multislice CT. | Q36488782 | ||
Diagnostic imaging of hepatocellular carcinoma in patients with cirrhosis before liver transplantation | Q36628332 | ||
Hepatocellular carcinoma: MRI and CT examination | Q36777651 | ||
The role of contrast-enhanced ultrasound for focal liver lesion detection: an overview | Q36873299 | ||
Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging | Q37068523 | ||
Multistep human hepatocarcinogenesis: correlation of imaging with pathology | Q37370018 | ||
Hypervascular liver lesions on MRI. | Q37904543 | ||
Understanding and optimizing use of contrast material for CT of the liver | Q40675218 | ||
The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy | Q43108443 | ||
Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA. | Q43273414 | ||
Development of well-differentiated hepatocellular carcinoma in large adenomatous hyperplasia after long-term follow-up: a case report. | Q43579523 | ||
Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients | Q44080950 | ||
Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT. | Q44107287 | ||
Biliary imaging with Gd-EOB-DTPA: is a 20-minute delay sufficient? | Q44227474 | ||
MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents | Q45155004 | ||
Current diagnostics and therapy for carcinomas of the biliary tree and gallbladder | Q46376041 | ||
New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases | Q46626413 | ||
The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver | Q46732729 | ||
Hepatocellular carcinoma: detection with diffusion-weighted versus contrast-enhanced magnetic resonance imaging in pretransplant patients. | Q46986748 | ||
Small hypervascular hepatocellular carcinoma revealed by double arterial phase CT performed with single breath-hold scanning and automatic bolus tracking | Q49021698 | ||
MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. | Q51652107 | ||
Evaluation of optimal timing of arterial phase imaging for the detection of hypervascular hepatocellular carcinoma by using triple arterial phase imaging with multidetector-row helical computed tomography. | Q51662506 | ||
Targeted sonography for small hepatocellular carcinoma discovered by CT or MRI: factors affecting sonographic detection. | Q53299046 | ||
Optimal arterial phase imaging for detection of hypervascular hepatocellular carcinoma determined by continuous image capture on 16-MDCT. | Q53398103 | ||
Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. | Q53508322 | ||
Imaging in the diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma. | Q53661215 | ||
Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. | Q54004869 | ||
Detection of hepatic metastases in colorectal cancer: a prospective study of laboratory and imaging methods. | Q54048870 | ||
MR imaging of intrahepatic cholangiocarcinoma | Q57736702 | ||
Hepatocellular Carcinoma: Role of Unenhanced and Delayed Phase Multi–Detector Row Helical CT in Patients with Cirrhosis | Q57944384 | ||
Black-Blood Diffusion-Weighted EPI Acquisition of the Liver with Parallel Imaging | Q61855611 | ||
Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging | Q67973184 | ||
CT of Fibrolamellar Hepatocellular Carcinoma | Q68243067 | ||
Prospective comparison of preoperative imaging and intraoperative ultrasonography in the detection of liver tumors | Q69359315 | ||
Imaging of intrahepatic cholangiocarcinoma: 1. Peripheral cholangiocarcinoma | Q71550055 | ||
Spiral CT for the detection of hepatocellular carcinomas:relative value of arterial- and late-phase scanning | Q71595213 | ||
Contrast enhancement technique for dynamic hepatic computed tomographic scanning | Q71717656 | ||
Differential diagnosis of focal liver lesions: role of spin-echo and contrast-enhanced dynamic MR imaging | Q72201232 | ||
Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T | Q72590816 | ||
Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging | Q73023378 | ||
Cholangiolocellular carcinoma of the liver: CT and MR findings | Q73112208 | ||
Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT | Q73834861 | ||
Contrast enhancement of small hepatocellular carcinoma: usefulness of three successive early image acquisitions during multiphase dynamic MR imaging | Q78201542 | ||
Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT--a comparative study | Q78227519 | ||
[Contrast enhanced ultrasound of the liver--state of the art] | Q80372369 | ||
Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions | Q81041133 | ||
[Multidetector computed tomography of the liver] | Q81169550 | ||
Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions | Q81631952 | ||
Determining the optimal timing for early arterial phase hepatic CT imaging by measuring abdominal aortic enhancement in variable contrast injection protocols | Q83181893 | ||
Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis | Q83220808 | ||
[Diffusion-weighted magnetic resonance imaging of the abdomen] | Q83675472 | ||
Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver | Q83767265 | ||
Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging | Q84178634 | ||
Cirrhosis and lesion characterization at MR imaging | Q84976974 | ||
P433 | issue | 5-6 | |
P407 | language of work or name | German | Q188 |
P304 | page(s) | 113-122 | |
P577 | publication date | 2013-02-08 | |
P1433 | published in | Wiener Medizinische Wochenschrift | Q2568998 |
P1476 | title | Radiological diagnosis of primary hepatic malignancy | |
P478 | volume | 163 |
Search more.